ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 686

Endothelial Dysfunction in Systemic Lupus Erythematosus Patients without Cardiovascular events and Risk Factors: Correlation with Microvascular Alterations and angiogenic t Cells

Ilaria Cavazzana1, Mara Taraborelli2, Silvia Piantoni3, Ivano Bonadei4, Edoardo Sciatti5, Micaela Fredi6, Marco Metra4, Angela Tincani7, Franco Franceschini1 and Enrico Vizzardi4, 1Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, 2Internal Medicine; Ospedale Mellini, Chiari (Brescia), Italy, 3Rheumatology and Clinical Immunology Unit, Spedali Civili, University of Brescia, Brescia, Italy, 4Cardiology Unit, Spedali Civili, University of Brescia, Brescia, Italy, 5Cardiology Unit, Spedali Civili, University of Brescia, Brsecia, Italy, 6Department of Rheumatology and Clinical Immunology, Rheumatology and Clinical Immunology, Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, 7Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Capillaroscopy, Cardiovascular disease, endothelial cells, lymphocytes and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: early identification of subclinical cardiovascular disease (CVD) in systemic lupus erythematosus (SLE) patients is mandatory to reduce morbidity and mortality. Endothelial dysfunction (ED) is one of the first steps of the process leading to atherosclerosis and has been associated with further CVD development. Aim of the study was to assess the prevalence of ED by a non invasive procedure in SLE patients with early disease without CVD and risk factors, and correlate ED with nailfold capillary morphology and angiogenic T (angT) cells. AngT cells are a T cell subpopulation, involved in repair mechanisms of the endothelium, cooperating with endothelial progenitors cells.

Methods: all the consecutive SLE patients, according to SLICC Classification Criteria, with a disease duration less than 5 years, evalued from december 2014 to march 2016 were proposed to participate to the study. Exclusion criteria were represented by history of CVD, diabetes, chronic renal disease (creatinine clearance<60 ml/min), not controlled systemic arterial hypertension, current or past smoking (in the last 3 years), hypercholesterolemia (total cholesterol>240 mg/dl), obesity (body mass index > or =30), statin or beta-blocker use. Each patient underwent a clinical and serological evaluation, a transthoracic doppler echocardiogram, endothelial function study by endoPAT technique, nailfold videocapillaroscopy (NVC) and T cell subpopulation study. Characteristics of patients with ED (ED+), defined as reactive hyperemic index < or= 2, were compared to those of patients without ED (ED-) and normal controls, matched for age, sex and CV exclusion criteria, by Fisher, T student or Mann-Whitney tests as appropriate.

Results: Among 46 screened SLE patients, 20 patients were enrolled (100% female, 80% caucasian) with a median disease duration of 14 months (0-68), a mean age of 42 years (±15), and a mean age at diagnosis of 40 years (±16). Arthritis, cutaneous and hematological features were found in 70%, 55% and 65% of cases, respectively. ANA, antidsDNA and anti-ENA were found in 100%, 50% and 50% of cases. Anti-cardiolipin and antibeta2glycoprotien I antibodies in 20% and 10%. ED was found in 8 patients (40%). ED didn’t correlate with any demographic-clinical-serological-echocardiographic features. A significantly higher prevalence of ED (p:0.003), vascular stiffness (p:0.02), left ventricular concentric remodelling (p:0.003), grade I diastolic dysfunction (p:0.04) were found in SLE patients compared to controls.

ED+ patients more frequently showed minor NVC abnormalities (i.e. tortuous,/crossed/enlarged) (p: 0,007), lower capillary number/mm (p: 0,01) and wider intercapillary distance (p: 0,06) compared to controls. AngT cells were significantly reduced in SLE patients compared to controls (p: 0,045), but they were increased in ED+ SLE compared to ED- (p: 0,04).

Conclusion: A significant proportion of SLE patients showed signs of ED despite a recent disease and the absence of cardiovascular risk factors. ED correlates with microvascular alterations by videocapillaroscopy and increased ang T cells, as marker of endothelium repair.


Disclosure: I. Cavazzana, None; M. Taraborelli, None; S. Piantoni, None; I. Bonadei, None; E. Sciatti, None; M. Fredi, None; M. Metra, None; A. Tincani, None; F. Franceschini, None; E. Vizzardi, None.

To cite this abstract in AMA style:

Cavazzana I, Taraborelli M, Piantoni S, Bonadei I, Sciatti E, Fredi M, Metra M, Tincani A, Franceschini F, Vizzardi E. Endothelial Dysfunction in Systemic Lupus Erythematosus Patients without Cardiovascular events and Risk Factors: Correlation with Microvascular Alterations and angiogenic t Cells [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/endothelial-dysfunction-in-systemic-lupus-erythematosus-patients-without-cardiovascular-events-and-risk-factors-correlation-with-microvascular-alterations-and-angiogenic-t-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/endothelial-dysfunction-in-systemic-lupus-erythematosus-patients-without-cardiovascular-events-and-risk-factors-correlation-with-microvascular-alterations-and-angiogenic-t-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology